Analysts forecast Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at CAGR of 10.67%

Published on April 11, 2014 at 6:12 AM · No Comments

The analysts forecast the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market to grow at a CAGR of 10.67 percent over the period 201-2016. One of the key factors contributing to this market growth is the high prevalence of abdominal aortic aneurysms. The Global Endovascular Abdominal Aortic Aneurysm Repair Devices market has also been witnessing the increasing demand for minimally invasive surgeries. However, the risk of complications and re-interventions associated with endovascular abdominal aortic aneurysm repair procedures could pose a challenge to the growth of this market.

The report, the Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Cook Medical Inc., Endologix Inc., Medtronic Inc., and W. L. Gore & Associates, Inc.

One of the main trends witnessed in the Global Endovascular Abdominal Aortic Aneurysm Repair Devices market is the increasing number of mergers and acquisitions. Several leading vendors in the Global Endovascular AAA Repair Devices market have been focusing on mergers and acquisitions strategy to increase its global presence, mitigate of patent expiration losses, and achieve high economies of scale.

For instance, Medtronic Inc. recently completed its acquisition of two privately held companies, PEAK Surgical Inc. and Salient Surgical Technologies Inc., to expand its innovative surgical product portfolio to meet the global customer and patient needs.

According to the report, one of the main factors driving the market is prevalence of favorable reimbursement policies. To minimize the overall cost for patients, some countries have provided insurance schemes through which patients can be reimbursed for the cost of the treatment incurred.

Further, the report states that one of the main challenges is the intense vendor competition. The global leading players are investing heavily in R&D to produce a broad range of advanced and high-end stents. Small and medium-sized vendors, however, are focused on marketing a single product line to a specific region in the globe, which is increasing the competition within the market.

Key Topics Covered:

1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
5. Scope of the Report
6. Market Landscape
7. Geographical Segmentation
8. Key Leading Countries
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
17. Other Reports in this Series

Companies Mentioned: 

  • Aptus Endosystems Inc.
  • Cardiatis S.A.
  • Cook Medical Inc.
  • Cordis Corp.
  • Endologix Inc.
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lombard Medical Technologies PLC
  • Medtronic Inc.
  • Nano Endoluminal
  • Terumo Cardiovascular Systems Corp.
  • TriVascular Inc..
  • W. L. Gore & Associates
Source:

Research and Markets

Posted in: Business / Finance

Tags: , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post